INT260166

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.61
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 6
Disease Relevance 0.43
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
eyes 6
Rpe65 (Mus musculus)
Pain Link Frequency Relevance Heat
Inflammation 18 5.00 Very Low Very Low Very Low
ketamine 6 5.00 Very Low Very Low Very Low
anesthesia 6 5.00 Very Low Very Low Very Low
dexamethasone 6 5.00 Very Low Very Low Very Low
cva 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Ganglion Cysts 12 74.36 Quite High
INFLAMMATION 18 5.00 Very Low Very Low Very Low
Cytomegalovirus Infection 18 5.00 Very Low Very Low Very Low
Adhesions 12 5.00 Very Low Very Low Very Low
Blister 12 5.00 Very Low Very Low Very Low
Toxicity 6 5.00 Very Low Very Low Very Low
Cataract 6 5.00 Very Low Very Low Very Low
Retinal Diseases 6 5.00 Very Low Very Low Very Low
Leber Congenital Amaurosis /

Leber Congenital Amaurosis

6 5.00 Very Low Very Low Very Low
Retina Disease 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
RPE65 expression following intravitreal and subretinal injections of scAAV5-smCBA-hRPE65 vector into rd12 mice
Positive_regulation (following) of Gene_expression (expression) of rd12
1) Confidence 0.61 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0
RPE65 expression following intravitreal and subretinal injections of scAAV5-smCBA-hRPE65 vector into rd12 mice
Positive_regulation (into) of Gene_expression (expression) of RPE65
2) Confidence 0.50 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0
Stable RPE65 expression throughout the whole retina was observed in the rd12 eyes five months after the subretinal injection of scAAV5-smCBA-hRPE65 (Figure 2A).
Positive_regulation (Stable) of Gene_expression (expression) of RPE65 in eyes
3) Confidence 0.50 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0
Stable RPE65 expression throughout the whole retina was observed in the rd12 eyes five months after the subretinal injection of scAAV5-smCBA-hRPE65 (Figure 2A).
Positive_regulation (observed) of Gene_expression (expression) of RPE65 in eyes
4) Confidence 0.50 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0
RPE65 expression following intravitreal and subretinal injections of scAAV5-smCBA-hRPE65 vector into rd12 mice
Positive_regulation (into) of Gene_expression (expression) of scAAV5-smCBA-hRPE65
5) Confidence 0.44 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0
Stable RPE65 expression throughout the whole retina was observed in the rd12 eyes five months after the subretinal injection of scAAV5-smCBA-hRPE65 (Figure 2A).
Positive_regulation (observed) of Gene_expression (injection) of scAAV5-smCBA-hRPE65 in eyes
6) Confidence 0.44 Published 2009 Journal Molecular Vision Section Body Doc Link PMC2633462 Disease Relevance 0.07 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox